CME OnDemand: 2022 AOFAS Annual Meeting-Successful Treatment of Recalcitrant Plantar Fasciitis and Achilles Tendonitis using Platelet-Rich Plasma (PRP) Injection, Short and Intermediate Results

Successful Treatment of Recalcitrant Plantar Fasciitis and Achilles Tendonitis using Platelet-Rich Plasma (PRP) Injection, Short and Intermediate Results

Back to course

Video Transcription

Video Summary

In this video, the speaker discusses the successful use of plasma-rich protein (PRP) in treating refractory chronic plantar fasciitis and Achilles tendonitis. The speaker started using PRP as an alternative to surgery due to the high cost and recovery time associated with surgical treatment. Patients with degenerative tendonitis or tendinosis were considered candidates for PRP, while those without degenerative changes were not eligible. The speaker performed a one-injection protocol, followed by post-injection care and regular follow-up assessments. Results showed that 68% of patients reported greater than 50% improvement at six to eight weeks post-injection, and long-term data indicated that over 85% of patients experienced continued improvement at an average of over two years after the PRP injection. The speaker concludes that PRP is an effective alternative for patients who have failed non-operative measures and have degenerative tissue or fascia at the site of pain and tenderness.

Asset Subtitle

Peter G. Mangone, MD, Emma L. Binns, and Spencer Bock

Keywords

plasma-rich protein

chronic plantar fasciitis

Achilles tendonitis

treatment

surgery alternative